Discovery and development of drugs that target signaling cascades controlled by G protein-coupled receptors continues to be a promising, though challenging, endeavor.

KXTbio, through its proprietary technologies, is positioned to be a leader in the study and screening of G protein-coupled receptors, GTPases and associated downstream effectors through the development, use and commercialization of innovative reagents, assays and screening platforms. We provide researchers with the right tools, including pure and active enzymes as well as robust, cost-effective assays of GTPases and their effectors. 

 Currently we focus on three major areas: